Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine CCP vs Placebo After Mastectomy
NCT02525211Phase 3Terminated
- Sponsor
- Institut Paoli-Calmettes
- Start
- Oct 2012
- Primary completion
- Apr 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine in postoperative pain, sponsored by Institut Paoli-Calmettes. Started Oct 2012; status: terminated.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02525211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02525211.